End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.22 CNY | -2.62% |
|
-1.30% | -28.35% |
Business Summary
Number of employees: 529
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Self-Selling Products
57.4
%
| 250 | 60.7 % | 238 | 57.4 % | -4.90% |
Active Pharmaceutical Ingredient
42.1
%
| 160 | 38.9 % | 174 | 42.1 % | +9.03% |
Trade
0.3
%
| 1 | 0.4 % | 1 | 0.3 % | -16.81% |
Other Business
0.2
%
| 0 | 0.0 % | 1 | 0.2 % | +727.26% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
63.9
%
| 206 | 50.0 % | 265 | 63.9 % | +28.70% |
Foreign
36.1
%
| 206 | 50.0 % | 149 | 36.1 % | -27.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gang Lu
CEO | Chief Executive Officer | 49 | 99-11-30 |
Chao Fei
DFI | Director of Finance/CFO | 45 | 05-05-31 |
Jian Li Ge
CHM | Chairman | 71 | 99-03-24 |
Hong Lin Huang
BRD | Director/Board Member | 62 | 99-03-24 |
Xiao Jing Yang
PRN | Corporate Officer/Principal | 42 | 06-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Yu
BRD | Director/Board Member | 58 | 19-09-30 |
Ping Wang
BRD | Director/Board Member | 75 | 19-11-25 |
Sun Liang Cui
BRD | Director/Board Member | 42 | 19-10-31 |
Jian Li Ge
CHM | Chairman | 71 | 99-03-24 |
Hong Lin Huang
BRD | Director/Board Member | 62 | 99-03-24 |
Gang Lu
CEO | Chief Executive Officer | 49 | 99-11-30 |
Wei Han Chen
CHM | Chairman | 50 | 99-06-30 |
Wen Juan Li
BRD | Director/Board Member | 43 | 12-02-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 154,713,824 | 54,469,269 ( 35.21 %) | 2,946,800 ( 1.905 %) | 35.21 % |
Company contact information
Chengda Pharmaceuticals Co., Ltd.
36 Huanghe Road Huimin Street
314100, Jiaxing
+
http://www.chengdapharm.com![address ChengDa Pharmaceuticals Co., Ltd.(301201)](https://cdn.zonebourse.com/static/address/133577001.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-28.35% | 392M | |
+63.05% | 854B | |
+39.42% | 636B | |
-4.78% | 361B | |
+17.52% | 324B | |
+8.43% | 301B | |
+14.19% | 247B | |
+5.81% | 230B | |
+16.77% | 228B | |
+14.63% | 177B |
- Stock Market
- Equities
- 301201 Stock
- Company ChengDa Pharmaceuticals Co., Ltd.